Zydus Cadila receives emergency approval for use on children above 12 years

Aug 21, 2021, at 04:29 am

New Delhi/IBNS: Zydus Cadila has received approval for Emergency Use Authorization (EUA) of its COVID-19 vaccine, ZyCoV-D, from the Drug Controller General of India (DCGI) to be administered on children and adults 12 years and above.

Zydus Cadila's COVID-19 jab likely to receive approval before August end

Aug 17, 2021, at 06:11 pm

New Delhi/UNI: Zydus Cadila's DNA vaccine could be the next COVID-19 jab to receive the authorisation approval from India's drug regulator.

Zydus Cadila seeks DCGI's emergency use approval for its 3-dose, 'needle free' vaccine : Reports

Jul 01, 2021, at 09:13 pm

New Delhi/IBNS: Gujarat-based pharma company Zydus Cadila has sought Drugs Controller General of India's (DCGI) approval for emergency use of its ZyCoV-D three-dose Covid shot which is the "world's first Plasmid DNA vaccine" and safe for children above the age of 12, according to media reports.

India reports over 48,000 COVID-19 cases, 1,005 deaths in 24 hours

Jul 01, 2021, at 04:29 pm

New Delhi/IBNS: In a slight increase in daily cases, India on Thursday reported 48,786 new COVID-19 infections besides registering 1,005 deaths apparently due to the virus in the last 24 hours.

Zydus Cadila seeks clinical trial approval for its antibody cocktail in India

May 27, 2021, at 08:35 pm

New Delhi/IBNS: Zydus Cadila has applied for regulatory approval for clinical trials of its antibody cocktail to treat mild Covid symptoms, said a Reuters reports

Zydus Cadila gets DCGI nod for human trials of Coronavirus vaccine

Jul 03, 2020, at 04:55 pm

Mumbai/UNI:  Pharma major, Zydus Cadila on Friday said it has received Drug Controller General of India (DCGI) nod to initiate phase1/11 human trials for its plasmid DNA vaccine candidate for COVID-19.